Immuron (IMRN) Other Accumulated Expenses (2016 - 2025)
Immuron (IMRN) posted quarterly Other Accumulated Expenses of $452.72 for Q3 2025, up 11.63% year-on-year from $405.56 in Q3 2024, and down 98.52% on a QoQ basis from $30496.2 in Q4 2024.
Immuron (IMRN) Other Accumulated Expenses (2016 - 2025) Analysis & Trends
Immuron (IMRN) has reported Other Accumulated Expenses for 9 consecutive years, with $452.72 the latest figure, recorded in Q3 2025.
- Quarterly Other Accumulated Expenses rose 11.63% year-over-year to $452.72 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $452.72 (up 11.63% YoY) and the FY2025 annual result came in at $452.72, up 11.63% from the prior year.
- Other Accumulated Expenses slipped to $452.72 in Q3 2025 per IMRN's latest filing, from $30496.2 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for IMRN reached as high as $38767.0 in Q2 2023 and fell as low as $144.76 in Q2 2021.
- A 5-year average of $14632.9 and a median of $14476.2 in 2021 frame the typical range for Other Accumulated Expenses.
- The largest YoY upside for Other Accumulated Expenses was 15868.49% in 2023 against a maximum downside of 98.85% in 2023.
- Year by year, Other Accumulated Expenses stood at $14476.2 in 2021, then surged by 67.7% to $24277.2 in 2022, then slumped by 98.85% to $280.03 in 2023, then surged by 10790.25% to $30496.2 in 2024, then slumped by 98.52% to $452.72 in 2025.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $452.72, $30496.2, and $405.56 for Q3 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 452.72 |
| Dec 31, 2024 | 30,496.19 |
| Sep 9, 2024 | 405.56 |
| Jun 30, 2024 | 28,641.65 |
| Dec 31, 2023 | 280.03 |
| Sep 28, 2023 | 27,378.21 |
| Aug 30, 2023 | 387.67 |
| Jun 30, 2023 | 38,767.00 |
| Dec 31, 2022 | 24,277.18 |
| Aug 31, 2022 | 24,277.18 |
| Jun 30, 2022 | 242.77 |
| Dec 31, 2021 | 14,476.19 |
| Jun 30, 2021 | 144.76 |
| Dec 31, 2020 | 415.45 |
| Sep 1, 2020 | 42,176.00 |
| Dec 31, 2019 | 421.76 |
| Jun 30, 2017 | 118,904.22 |
| Dec 31, 2016 | 52,926.60 |